Delivery Order SPE2DB20D1100-SPE2DB25FA8M3

Award Date 2/28/25
Potential Completion Date 3/3/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,768.94 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a prescription medication. The contract has an ultimate completion date of May 17, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, with a ceiling value of $3,906.14. The contract has a performance period through June 12, 2024 and is a firm fixed-price type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,011.48, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA, which serves as a primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of RYTARY ER 23.75 MG-95 MG CAP 100S, a specialty medication. The contract has a ceiling value of $2,142.00 and a completion date of August 6, 2024. It is a firm-fixed-price contract, indicating a set price for the delivered items. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $28,874.37, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,829.51, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 9, 2024. This award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of RYTARY ER 61.25 MG-245 MG CAP 100S, a prescription medication. The contract has a ceiling value of $2,680.50 and a period of performance through January 7, 2025. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a $6,330.91 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for RYTARY ER 36.25 MG-145 MG CAP 100S, a pharmaceutical product. The contract has a period of performance through January 3, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,325.98, is for the delivery of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of January 9, 2025. The contract was not set aside for any specific type of business. AmerisourceBergen holds a...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,761.74, is for the delivery of 4567117581 RYTARY ER 48.75 MG-195 MG capsules in lots of 100. The contract is a Firm Fixed Price type, with a period of performance through February 3, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA8M3
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product, at a ceiling value of $1,497.39. The contract is a firm fixed-price delivery order with an ultimate completion date of March 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award was not designated with a set-aside requirement.

Generated 5/30/25, 9:55 AM